Transcriptomics

Dataset Information

0

Adipose METTL14-elicited N6-methyladenosine promotes obesity, insulin resistance, and NAFLD by suppressing β adrenergic signaling and lipolysis


ABSTRACT: Obesity is associated with impaired β-adrenergic receptor (Adrb1-3) signaling and lipolysis, leading to aberrant white adipose tissue (WAT) growth. WAT research has been centered on transcriptional and posttranslational regulations, but posttranscriptional regulation and mRNA modifications are poorly understood. Here, we unveil a METTL14/N6-methyladenosine (m6A) paradigm guiding β-adrenergic signaling and lipolysis. METTL14 complex installs m6A on RNA, regulating mRNA fate and translation. We found that feeding and insulin increased adipose Mettl14 and m6A levels. Adipose Mettl14 and m6A were upregulated in high fat diet (HFD)-induced obesity. Ablation of adipose Mettl14 decreased Adrb2, Adrb3, Atgl (encoding lipase), and Cig-58 (Atgl activator) transcript m6A contents while increasing their translation and protein levels, thereby enhancing adipose β-adrenergic signaling and lipolysis. Consequently, adipocyte-specific Mettl14 knockout mice were resistant to HFD-induced obesity, insulin resistance, glucose intolerance, and NAFLD. These results unravel a METTL14/m6A-based epitranscriptomic mechanism governing β-adrenergic signaling, lipolysis, and adipose growth in health and disease.

ORGANISM(S): Mus musculus

PROVIDER: GSE233782 | GEO | 2023/06/04

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2019-04-23 | GSE130147 | GEO
2021-11-01 | GSE178762 | GEO
2021-01-01 | GSE142424 | GEO
2008-02-03 | E-MARS-8 | biostudies-arrayexpress
| PRJNA977972 | ENA
2014-03-15 | E-GEOD-55934 | biostudies-arrayexpress
2023-02-03 | GSE178884 | GEO
2013-06-01 | E-GEOD-43104 | biostudies-arrayexpress
2019-12-19 | GSE142295 | GEO
2019-12-19 | GSE142294 | GEO